MedPath

Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients

Not Applicable
Recruiting
Conditions
Pulmonary Embolism
Deep Vein Thrombosis
Interventions
Diagnostic Test: Proximal lower limb ultrasound
Registration Number
NCT05112705
Lead Sponsor
King Abdullah International Medical Research Center
Brief Summary

The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.

Detailed Description

This is an open-label multicenter multinational randomized-controlled trial. All patients admitted to ICU will be screened within the first 48 hours of ICU admission for eligibility. Subjects who meet all criteria for enrollment will be randomized via a password-protected, secure website using a variable-size block concealed computer-generated randomization procedure. Patients will be allocated to twice weekly bilateral lower limb ultrasound or standard care (control) in a 1:1 ratio.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1800
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ultrasound GroupProximal lower limb ultrasoundPatients will be receiving twice weekly proximal lower limb ultrasound
Primary Outcome Measures
NameTimeMethod
90-day mortality90 days

Mortality 90 days post randomization

Secondary Outcome Measures
NameTimeMethod
Proximal DVTFrom randomization date to day 28 or ICU discharge whichever comes first

Lower limb proximal leg DVT, defined as partially or completely incompressible venous segment.

Pulmonary EmbolismFrom randomization date and throughout hospital stay up to day 28

Pulmonary embolism defined as definite PE (characteristic intraluminal filling defect on CT chest, high probability VQ scan or detected at autopsy); probable PE (moderate-high pretest, no test or a non-diagnostic test); possible PE (low pre-test probability, non-diagnostic test) or No PE (negative or normal test)

Clinically important bleedingFrom randomization date and throughout hospital stay up to day 90

Fatal bleeding, symptomatic bleeding in critical organ or bleeding causing fall in hemoglobin, requiring transfusion or interventional radiology

Trial Locations

Locations (1)

King Abdulaziz Medical City

🇸🇦

Riyadh, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath